These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 38106674)

  • 1. Microphysiological systems for solid tumor immunotherapy: opportunities and challenges.
    Abizanda-Campo S; Virumbrales-Muñoz M; Humayun M; Marmol I; Beebe DJ; Ochoa I; Oliván S; Ayuso JM
    Microsyst Nanoeng; 2023; 9():154. PubMed ID: 38106674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies.
    Campisi M; Shelton SE; Chen M; Kamm RD; Barbie DA; Knelson EH
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling immunity in microphysiological systems.
    Kwee BJ; Li X; Nguyen XX; Campagna C; Lam J; Sung KE
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2001-2019. PubMed ID: 38166397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphysiological Systems for Cancer Immunotherapy Research and Development.
    Peng Y; Lee E
    Adv Biol (Weinh); 2024 Aug; 8(8):e2300077. PubMed ID: 37409385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.
    Daniel SK; Sullivan KM; Labadie KP; Pillarisetty VG
    Clin Transl Med; 2019 Apr; 8(1):10. PubMed ID: 30931508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Microphysiological Immune System Responses on Chips.
    Miller CP; Shin W; Ahn EH; Kim HJ; Kim DH
    Trends Biotechnol; 2020 Aug; 38(8):857-872. PubMed ID: 32673588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.
    Brempelis KJ; Cowan CM; Kreuser SA; Labadie KP; Prieskorn BM; Lieberman NAP; Ene CI; Moyes KW; Chinn H; DeGolier KR; Matsumoto LR; Daniel SK; Yokoyama JK; Davis AD; Hoglund VJ; Smythe KS; Balcaitis SD; Jensen MC; Ellenbogen RG; Campbell JS; Pierce RH; Holland EC; Pillarisetty VG; Crane CA
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors.
    Fogli LK; Aurigemma R; Sommers CL; Singh A; Bourcier K; Ernstoff MS;
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Liver Microphysiological Systems for Biomedical Applications.
    Wang J; Wu X; Zhao J; Ren H; Zhao Y
    Adv Healthc Mater; 2024 Aug; 13(21):e2302217. PubMed ID: 37983733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineered tissue models for the development of dynamic immuno-associated tumor models and high-throughput immunotherapy cytotoxicity assays.
    Seyfoori A; Barough MS; Amereh M; Jush BK; Lum JJ; Akbari M
    Drug Discov Today; 2021 Feb; 26(2):455-473. PubMed ID: 33253917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging NKG2D Ligands in Immuno-Oncology.
    Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():713158. PubMed ID: 34394116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic technologies for immunotherapy studies on solid tumours.
    Paterson K; Zanivan S; Glasspool R; Coffelt SB; Zagnoni M
    Lab Chip; 2021 Jun; 21(12):2306-2329. PubMed ID: 34085677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microphysiological systems as models for immunologically 'cold' tumors.
    Gaebler D; Hachey SJ; Hughes CCW
    Front Cell Dev Biol; 2024; 12():1389012. PubMed ID: 38711620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune cell contexture in the tumor microenvironment].
    Fujii SI
    Rinsho Ketsueki; 2020; 61(9):1424-1432. PubMed ID: 33162545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape.
    Rodriguez-Garcia A; Palazon A; Noguera-Ortega E; Powell DJ; Guedan S
    Front Immunol; 2020; 11():1109. PubMed ID: 32625204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in CAR-Based Solid Tumor Immunotherapy.
    Shin MH; Oh E; Kim Y; Nam DH; Jeon SY; Yu JH; Minn D
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.